Results for "Understanding Pharmaceutical Distribution"
Understanding Healthcare Distributors and The Industry’s Role in the Supply Chain
There is a lot of talk right now in Washington about healthcare “middlemen.” However, this term is sometimes used too broadly, lumping together sectors with dramatically different roles and contributions to the overall healthcare system.
Advocacy in Action: TopRx Provides On-the-Ground Perspective During Rep. Kustoff’s Facility Visit
On May 4, HDA distributor member company TopRx gave a tour of their headquarters in Bartlett, Tenn., to Representative David Kustoff (R-Tenn.-08).
Supply Chain Experts Discuss the Future of the U.S. Pharmaceutical Cold Chain
HDA hosted a LinkedIn Live event exploring the challenges, successes and future of the U.S. pharmaceutical cold chain. The event delved into key findings from the HDA Research Foundation’s report, The Future of the U.S. Pharmaceutical Cold Chain, and featured perspectives from Jeffrey Gainer, Business Process Senior Manager at McKesson, and Rena K. Goins, Executive Director of Global Trade and Distribution at Regeneron. HDA’s Perry Fri, EVP of Industry Relations and Member Services and COO of the HDA Research Foundation, moderated the discussion. Here are three takeaways from the discussion.
HDA Issues Policy Platform Addressing Drug Shortages
HDA and its pharmaceutical distributor members released a policy agenda to combat drug shortages, centering around three core themes: federal coordination, strategic investment and end-to-end stabilization of the generic drug supply chain.